RESMED INC — Director's Dealing 2018

Jan 29, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-01-26

Reporting Person: WAREHAM JOHN P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-26	ResMed Common Stock	M	25934	$38.98	Acquired	38934	Direct
2018-01-26	ResMed Common Stock	S	17634	$102.09	Disposed	21300	Direct
2018-01-26	ResMed Common Stock	S	8300	$102.60	Disposed	13000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-26	Resmed Common Stock Options	$38.98	M	25934	Disposed	2019-11-15	ResMed Commmon Stock (25934)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $101.49 to $102.49. The price reported above reflects the weighted average sale price.

F2: This transaction was executed in multiple trades at prices ranging from $102.49 to $102.73. The price reported above reflects the weighted average sale price.

F3: Represents the date options became exercisable. Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date.